A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects

NCT02074358 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Anticoagulation

Interventions

DRUG: Apixaban
DRUG: Cofact (4-Factor PCC)
DRUG: Beriplex P/N (4-Factor PCC)
DRUG: Placebo (Saline solution)

Sponsor

Bristol-Myers Squibb